Poolbeg Pharma ups retail raise amid ‘strong investor interest'

  • Poolbeg Pharma PLC (AIMOLB) has expanded its BookBuild Offer, part of a larger funding, citing strong investor interest. The company, in a statement, said it is now offering 6 million shares in the process, to potentially raise  £150,000 of gross proceeds.